back to top
HomeTagsAsahi

Asahi

Calliditas Therapeutics inventory goal minimize on Asahi Kasei's acquisition supply By Investing.com

On Tuesday, Stifel, a monetary companies agency, downgraded shares of Calliditas Therapeutics (NASDAQ:CALT) from "Buy" to "Hold," adjusting the worth goal to $40, down...

Most Popular

spot_img